Company Presentation
Investors — NMD Pharma
NMD Pharma
NMD Pharma - Capnova
Management — NMD Pharma
NMD Pharma
NMD bags €38M to run orphan neuromuscular disease trials | FierceBiotech
Management — NMD Pharma
Big deal: NMD flexes series A muscles - Global University Venturing
Management — NMD Pharma
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma company information, funding & investors | Dealroom.co
Contact — NMD Pharma
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
Management — NMD Pharma
NMD Pharma — NMD Pharma
NMD Pharma A/S | LinkedIn
Event: Aarhus - Brew Your Own: Meet the founders - Biopeople
